Catalyst Wire Dossier Catalyst Wire Dossier

Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product

· Samsung Medical Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product, covering 2015-01-14 to 2015-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product [EARLY_Phase 1]

See pricing